Angela D. Ritter, M.D. – 681999 – 06/07/2024
Clinical Investigator (Sponsor)
GFA Production Xiamen Co., Ltd. – 678364 – 06/13/2024
CGMP/Finished Pharmaceuticals/Adulterated
Auro Pharmacies, Inc., dba Central Drugs Compounding Pharmacy – 608369 – 06/03/2020
CGMP/Drug Products/Adulterated
Center for Wellness and Integrative Medicine – 608693 – 06/30/2020
Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19)
Only Natural, Inc. dba Bio Nutrition, Inc. – 605076 – 06/18/2020
Unapproved New Drugs/Misbranded
FDA Roundup: March 21, 2025
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
Antimicrobial Resistance
Antimicrobial resistance (AMR)—the ability of a microorganism (bacteria, virus, fungi, parasite) to resist the effects of a drug—is a serious,…
FDA Patient-Focused Drug Development Guidance Series for Enhancing the Incorporation of the Patient’s Voice in Medical Product Development and Regulatory Decision Making
FDA Patient-Focused Drug Development Guidance Series for Enhancing the Incorporation of the Patient’s Voice in Medical Product Development and Regulatory…
CDER Pilot Grant Program: Standard Core Clinical Outcome Assessments (COAs) and their Related Endpoints
The U.S. Food and Drug Administration (FDA) has developed a Pilot Grant Program to support the development of publicly available…
Condition-Specific Meeting Reports and Other Information Related to Patients’ Experience
This webpage provides links to certain publicly available external reports and resources relating to patient experience data. The patient community,…